A prominent researcher in the health and nutrition space said a CBD observational study would not answer all of the safety questions raised by FDA about specific products in the U.S. market.
There is more to the hemp plant than CBD and THC. Perhaps more than 100 other cannabinoids are present in the plant, as well as aromatic terpenes and other compounds. Dig in!
Many consumers who have begun taking supplements because of COVID-19 say they are long-term customers looking to take control of their health and wellness, according to recent research. The shift to online buying has been accelerated as well.
In a letter to FDA's commissioner, Dr. Stephen Hahn, lawmakers from four states suggested it would be a "fool's game" for the agency to try to keep kratom from consumers.
The future of CBD is bright, though federal regulations that restrict incorporating the ingredient into food and beverage products could curtail its growth potential. And because FDA has not set guidelines that hold CBD suppliers accountable for...
In a letter to President Trump, seven hemp organizations suggested his administration could work with Congress on a legislative solution to resolve a barrier facing the CBD industry.
The human trials could help answer safety questions for FDA officials, who are continuing to examine potential pathways for the lawful marketing of various CBD products in the U.S.
Jeff Crowther, executive director of Health Products Association-China (HPA-China), weighs in on U.S.-China trade issues, coronavirus, the impact on the supplement industry and the evolution of his trade group.
